Skip to main navigation
  • Contact Us
  • Investors
Logo
  • 800-449-3353

  •  custserv@rockwellmed.com

  • Home
  • About Rockwell
    • Corporate Overview
    • Company History
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
    • Contact Us
  • Therapeutic Focus
    • Kidney Disease
      • Dialysis & Hemodialysis
    • Chronic Kidney Disease
    • Anemia and Iron Deficiency
    • Anemia and Kidney Disease
    • Triferic®
      • Triferic MOA
      • Triferic Clinical Development Progress
    • Calcitriol Vial
  • Bio-Pharma Development
    • Product Pipeline
  • Dialysis Products
    • Dialysis Products
      • Hemodialysis Concentrates
      • CitraPure
      • Dri-Sate
      • Safety Data Sheets
      • Ancillary Products
      • Renal Pure
    • Rockwell Customer Service
    • Rockwell Transportation and Delivery
  • Media Center
    • Media Center
    • Links to Additional Resources
    • Publications

Main navigation

  • Investor Home
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Management
  • Annual Meeting
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
    • Financial Statements
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Dividend History
    • Analyst Coverage
    • Ownership Profile
  • Investor FAQs
  • Contact Us
  • Shareholder Tools

Investor Relations

Latest News

  • February 5, 2019 at 5:00 PM EST
    Summary ToggleRockwell Medical, Inc. to Present at 2019 BIO CEO & Investor Conference
  • December 27, 2018 at 7:00 AM EST
    Summary ToggleRockwell Medical, Inc. Shareholder Letter

View all releases »

Stock Information

Stock Controls

  • 3 mo.
  • 6 mo.
  • 1 yr.
  • Home
  • About Rockwell
  • Therapeutic Focus
  • Bio-Pharma Development
  • Dialysis Products

© 2019 Rockwell Medical